{{Rsnum
|rsid=1412337
|Chromosome=1
|position=168649403
|Orientation=minus
|GMAF=0.1942
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 60.2 | 33.6 | 6.2
| HCB | 54.4 | 40.4 | 5.1
| JPT | 50.4 | 42.5 | 7.1
| YRI | 72.8 | 25.2 | 2.0
| ASW | 78.9 | 19.3 | 1.8
| CHB | 54.4 | 40.4 | 5.1
| CHD | 54.1 | 38.5 | 7.3
| GIH | 63.4 | 35.6 | 1.0
| LWK | 83.5 | 13.8 | 2.8
| MEX | 63.8 | 32.8 | 3.4
| MKK | 73.7 | 25.0 | 1.3
| TSI | 72.5 | 24.5 | 2.9
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs1412337
|PubMedID=17903295
|Condition=Morbidity-free survival
|Gene=DPT
|Risk Allele=
|pValue=2.00E-009
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs1412337
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:17903295; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study. (Initial Sample Size: 1,345 individuals (Framingham); Replication Sample Size: NR). This variant is associated with Morbidity-free survival.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356446
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1412337
|overall_frequency_n=15
|overall_frequency_d=128
|overall_frequency=0.117188
|n_genomes=14
|n_genomes_annotated=0
|n_haplomes=15
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}